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Abstract
Background: Southern China is an endemic area for primary liver cancer (PLC), but it is unclear if rates have
changed in recent decades. We evaluated PLC incidence and estimated the effects of age, period of diagnosis, and
birth cohort in Sihui City, Guangdong Province, China.
Methods: Age-standardized rates (ASRs) of PLC were examined for both males and females from 1987 to 2011.
Joinpoint regression analysis was conducted to estimate the annual percent changes in PLC incidence. The age-
period-cohort (APC) model was used to investigate the effects of age, diagnosis period, and birth cohort on the
relative risk (RR) of PLC.
Results: A total of 2988 PLC cases were identified in this period, with average ASRs of 51.1/100,000 for males and
11.7/100,000 for females. Joinpoint regression analysis revealed increasing PLC incidence throughout the entire
period in both males (average annual change of 1.65 %) and females (0.20 %). RRs increased gradually in both sexes
from the youngest age group (30–34 years) to the oldest (80–84 years). In males, the RR decreased during diagnosis
period from 1987–1991 to 1997–2001 and remained stable thereafter. In females, RRs fluctuated with diagnosis
period throughout the entire period. Incidence tended to increase with birth cohort from 1905–1909 to 1975–1979
in both males and females; however, female incidence plateaued in the youngest cohorts born between 1955 and
1974, while incidence in males increased sharply in the cohorts born between 1965 and 1974. According to APC
analysis, the full age-period-cohort (APC) model fit the data best, and the period-cohort (PC) model would be
enough to explain variability of rates in females.
Conclusion: The PLC incidence rate in males of Sihui City has increased more significantly than female over the last
25 years. Despite the age effect in male, this trend mainly reflects the effects of risk factors that are present in early
life (birth cohort) and period change in both genders.
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Background
Primary liver cancer (PLC) is one of the most common
cancers worldwide, ranked the fifth most frequent malig-
nancy in males (age-standardized rate (ASR) of 15.3/
100,000) and the ninth in females (ASR of 5.4/100,000)
[1]. The geographic distribution of PLC is very uneven,
with almost 85 % of cases in developing countries and
highest incidence rates in Southeast Asia and sub-
Saharan Africa [2, 3]. In most populations, the major
histological type of PLC is hepatocellular carcinoma
(HCC), followed by cholangiocarcinoma (CC) and
combined hepatocellular and cholangiocarcinoma
(cHCC-CC) [4].
Up to 80 % of PLC worldwide is associated with
chronic hepatitis B virus (HBV) and hepatitis C virus
(HCV) infections [5]. Infection by HBV is the most com-
mon risk factor for PLC in Asia, and prospective cohort
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studies have found a 5- to 100-fold increase in HCC risk
among persons chronically infected with HBV [5, 6].
Exposure to aflatoxin, a mycotoxin from Aspergillus
molds, is the second most common cause in most en-
demic regions of China [7]. In southern China, including
Guangdong and Guangxi Provinces, liver and biliary
disorders, especially cholangiocarcinoma, are primarily
associated with infection by the liver fluke Clonorchis
sinensis [8, 9]. Other possible environmental and life-
style risk factors for PLC have also been identified,
such as alcohol-related liver diseases, obesity, and
smoking [10, 11].
In China, PLC was the third most common cancer in
males (268,757 new cases with ASR of 32.2/100,000) and
the fifth most common in females (90,083 new cases
with ASR of 10.4/100,000) in 2010 [12]. According to
the first national death study, the endemic are located in
the southern, southeastern, southwestern and northeast-
ern areas of China, such as Guangdong, Jiangsu,
Zhejiang, Guangxi and Heilongjiang [13]. Several studies
have reported a decreasing trend in some epidemic re-
gions of China, such as Shanghai, Qidong and Fusui
[14–16], but changes in PLC incidence have not been
examined in southern China. The objective of our study
was to describe the changes in PLC incidence during the
last 25-year period (1987–2011) in Sihui, Guangdong
Province, southern China. These changes may identify




Sihui is a county-level city located in the central part of
Guangdong Province. In 2011, the population of Sihui
was 418,097 and >75 % lived in rural residences. The
major industries include jade processing, smelting,
metallurgic casting, and ceramic manufacturing. Climate
in Sihui is warm and humid all year around, and the
main economic crops are rice and oranges. According to
previous reports, the most common malignancy in Sihui
is PLC, accounting for 24.56 % of the total [17, 18].
Thus, PLC is an enormous economic and social burden
in this region.
Data sources
Since the establishment of a national three-level can-
cer network in 1987, a malignant tumor registration
report system has been implemented in Sihui [19].
All cancer cases are regularly reported (approximately
once a month) by local general practitioners to the
central hospital of each town, and then reported to
Sihui Cancer Institute once every 3 months. Health
specialists assigned by Sihui Cancer Institute collect
the reports, record the information onto predesigned
cards, and check the quality of the data. To reduce
the possibility of missing reports, cancer institute staff
also collect the tumor data from hospitals in Sihui
once every half year since 1998. For this study, the
demographic data (age composition by sex) from
1987 to 2011 were collected from the population
information published by the Sihui Statistics
Department.
During the 1987–2011 period, 2988 cases of malig-
nant neoplasm of the liver (ICD10 = C22) were identi-
fied from Sihui Cancer Registry Institute. The basic
registration data, including sex, age, birth date, family
history, pathological basis, diagnostic date, disease
stage at diagnosis, International Classification of
Diseases-10th revision (ICD-10) code, cause of death,
registered identification number, and national identifi-
cation number, were collected from the cancer report-
ing cards. Among 2988 cases, 675 cases (22.59 %)
were from the histologic diagnosis, 79 cases (2.64 %)
were from cytological or biochemical or immune
deduction, 1674 cases (56.02 %) were from B-
Ultrasonograph or other medical imaging, and 373
cases (12.49 %) were from clinical detection. The
number of death certification notifications (DCN)
cases was 187 (6.26 %), and the ratio of mortality to
incidence (M: I) was 94.88 %. This study was
approved by the Institutional Research Ethics
Committee of Sun Yat-sen University Cancer Center
(YB2016-034). In this study, only annual cancer regis-
tration report data was used and no information to
identify individual subjects was included.
Statistical methods
In order to estimate age-standardized incidence rates
of liver cancer, data stratified by sex were arranged
into five shorter intervals (1987–1991, 1992–1996,
1997–2001, 2002–2006 and 2007–2011) for the time
period 1987–2011. All age-adjusted incidence rates
were calculated using direct standardization with the
Segi’s World Standard Population (1960) [20].
Joinpoint regression was used to estimate annual per-
cent changes (EAPCs). Significant joinpoints were iden-
tified by permutation tests using 95 % of the asymptote
[21], starting with no joinpoints and adding up to three
to the model [22].
An age-period-cohort (APC) model was used to es-
timate the incidence of PLC. Regression analysis con-
sidered the effects of three factors on incidence for
each gender: age, period, and cohort [23]. The model
assumed that the number of liver cancer cases follows
a Poisson distribution and that incidence rates are a
multiplicative function of the included model parame-
ters, making the logarithm of the rates an additive
function of the parameters [24, 25]. Relative risks
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(RRs) were calculated to show the effects of age, diag-
nosis period, and birth cohort in the APC models. All
analyses were restricted to the 30–84 years age range
and data were categorized into 11 age groups from
30–34 years to 80–84 years when applied to the APC
model, together with 5 diagnosis period groups
(1987–1991 to 2007–2011) and 15 birth cohort
groups (1905–1909 to 1975–1979) (Table 4 in
Appendix). To make this model more stable, we
chose the 55–59 year age group, the 1997–2001 diag-
nosis period group, and the 1940–1944 birth cohort
group as references instead of the first or the last
group [26]. Goodness of fit of the models was
assessed both by deviance and Akaike’s information
criterion (AIC). Ratios of deviance to the degrees of
freedom were closer to 1 and lower AIC values indi-
cated a better fit [27, 24, 25]. All analyses were per-
formed using SAS 9.3 (Version 9.3, SAS Institute Inc.,
NC, USA).
Results
PLC incidence in Sihui
Over the 25-year study period from 1987 to 2011,
2988 PLC cases were identified in Sihui. Of these,
2380 (79.7 %) were diagnosed in men and 608
(20.3 %) in women. The crude incidences were 33.74/
100,000 for the total population, 47.01/100,000 for
males, and 12.64/100,000 for females between 1987
and 2011. The corresponding ASRs were 30.83/
100,000 for the total population, 51.14/100,000 for
males, and 11.69/ 100,000 for females. The overall
age-adjusted rates among males and females increased
in this period, from 32.49/100.000 to 69.54/100,000 in
male and 7.03/100,000 to 13.43/100,000 in female
(Table 1, Fig. 1).
Joinpoint regression analysis of PLC incidence
During the 25-year period, three-joinpoint model was
obtained as the best model for both sexes, and the inci-
dence of PLC fluctuated with increasing trend at an
average annual percent change of 1.65 % for males and
0.20 % for females (Fig. 2).
Age-period-cohort effects on PLC incidence
In males, the full APC model fit the data best with
the Deviance =42.96, AIC = 10352. Among females, a
period-cohort model was sufficient to explain variabil-
ity of the PLC incidence, since a non-significant
(ΔDeviance) between the age-period-cohort (Deviance
= 28.95) and the period-cohort (Deviance =42.19; p =
0.152) models was found. The Δdeviance of corre-
sponding models of age-period (Δdeviance = 47.04)
was higher than period-cohort (Δdeviance = 13.24)
indicated that the birth cohort effect was more
important than the age effect in female (Table 2). The
component effects in the final APC model are shown
in Table 3. The age effects for both sexes showed that
the risk of PLC had consistent increasing trends with
age. Compared with the age group of 55–59 years,
the RR of PLC was up to 3.61(95 % CI:2.20–5.96) for
males and 3.86 (95 % CI:1.78–8.36) for females in the
oldest age group (80–84 years) (Fig. 3a). Period ef-
fects for males depicted that the RRs decreased from
1987–1991 to 1997–2001, and then plateaued after-
wards; for females, RRs fluctuated through the entire
period (Fig. 3b). By using the 1940–1944 birth cohort
as the reference group, an obvious increased inci-
dence trend in both males and females were obtained;
however, females had a plateau in the youngest co-
horts who were born during 1955–1974 and males
had a sharp increasing trend in the cohorts who were
born during 1965–1974 (Fig. 3c).
Discussion
This study reveals that the incidence rate of PLC in
Sihui (30.8/100,000) was substantially higher than the
national level (10.1/100,000) during the period 1987–
2011 [1]. Moreover, the average ASR in this region
exhibited an increasing trend over this period, in con-
trast to three other endemic regions of China,
Shanghai [14], Qidong [15], and Fusui [16], where in-
cidence rates are stable or declining. The APC ana-
lysis revealed that the increasing trend of PLC
incidence in Sihui is primarily due to the effects of
period changes and a spike in the younger cohorts,
particularly males born between 1965 and 1974. Such
a pattern may indicate the impact of lifestyle and en-
vironmental changes on the risk of PLC in rural areas
of southern China.
Reasons for the high incidence of PLC in Sihui are
not completely clear but may be related to higher
HBV infection rates and other possible infection risk
factors compared to other regions of China. A sur-
vey conducted between 1992 and 1995 reported the
highest HBV infection rate in Guangdong compared
to the rest of China, with HBs-Ag positive rate of
17.85 % in the general population and 19.86 % in
children aged <15 years. Among children aged <15,
age-specific prevalence rates of HBs-Ag was 23.68,
14.63, 17.5319.6118.71, and 23.84 % in the 6 age
groups (1-, 2–3, 4–5, 6–7, 8–9, 10–14 years), re-
spectively [28–30]. Hence, reducing HBV infection is
critical for controlling PLC in southern China. Hepa-
titis B vaccination of neonates and infants is the
most effective way of eliciting protective antibodies
to HBV surface antigen (anti-HBs) and in reducing
the prevalence of HBs-Ag among children [31, 32].
Since 2002, subsidy for HBV vaccination has been
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Table 1 Age-standardized rates of primary liver cancer incidence in Sihui City, Guangdong Province, China from 1987 to 2011
Year Males Females
Cases Crude incidence (/100,000) ASR (/100,000) Cases Crude incidence (/100,000) ASR (/100,000)
1987 50 29.27 32.49 13 7.66 7.03
1988 61 35.30 39.35 12 7.06 6.56
1989 68 39.32 43.50 17 9.79 8.93
1990 80 44.69 48.72 19 10.87 11.14
1991 82 46.07 49.74 23 13.03 11.38
1992 96 52.70 55.36 31 17.46 15.84
1993 102 55.06 58.87 24 13.40 13.09
1994 72 38.19 40.19 24 13.31 12.45
1995 97 50.88 52.39 35 19.22 17.76
1996 70 36.17 41.28 23 12.53 13.62
1997 81 41.29 49.69 29 15.66 15.18
1998 68 33.85 38.25 22 11.67 11.12
1999 78 38.69 44.73 20 10.50 10.16
2000 93 45.92 48.15 31 16.22 14.01
2001 76 37.29 38.42 22 11.44 10.72
2002 84 41.09 42.85 20 10.34 9.86
2003 92 44.72 43.94 21 10.82 9.22
2004 121 58.29 62.15 15 7.73 6.40
2005 117 55.57 56.88 26 13.31 10.30
2006 114 53.82 55.28 21 10.63 9.54
2007 140 66.11 67.72 29 14.67 12.04
2008 140 66.38 69.36 33 16.50 14.52
2009 126 59.62 62.12 39 19.31 16.08
2010 133 62.76 66.30 25 12.30 10.28
2011 139 65.08 69.54 34 16.62 13.43
total 2380 47.01 51.14 608 12.64 11.69
ASR Age-standardized rates
Fig. 1 Age-standardized rates of primary liver cancer incidence by sex using the moving average in three-year intervals in Sihui, China, 1987–2011. The
overall age-adjusted rate among males and females was increased in this period, from 32.49/100.000 to 69.54/100,000 in male and 7.03/100,000 to 13.43/
100,000 in female (Fig. 1)
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provided for all infants and has thereafter largely re-
duced HBV infection rate among Chinese children
[31, 32]. However, HBV infection remains highly
prevalent in the population born before the vaccin-
ation program and the incidence of PLC has
remained high in adults. Since hepatitis B vaccine is
proven to prevent HBV infection among children
and teenagers, it may also prove beneficial to young
adults in preventing HBV induced PLC [31].
Clonorchis sinensis (C. sinensis) infection is another
possible contributor to the high incidence of PLC in
Sihui. Clonorchiosis is also common in Guangdong, with
heavily endemic areas located along the Pearl River Delta
[33]. Raw freshwater fish is a staple of the Cantonese
diet in this region, and these fish act as the second inter-
mediate host in the lifecycle of C. sinensis. Research
showed that Clonorchis sinensis infection is strongly
related to liver and biliary disorders, especially
Fig. 2 Trends in world age-standardized rates (ASR-W) of PLC incidence for both sexes in the period of 1987–2010 in Sihui, China, with joinpoint
regression. During the 25-year period, three-joinpoint model were obtained as the best model for both sexes and the incidence of PLC fluctuated
with increasing trend at an average annual percent change of 1.65 % for males and 0.20 % for females (Fig. 2)
Table 2 Age-period-cohort models for PLC incidence rates in Sihui, China
DF Deviance Deviance/DF ΔDeviance ΔDF P AIC
Male
Age 44 157.34 3.58 114.38 17 <0.001 10432
Period 50 1103.36 22.07 1060.04 23 <0.001 11366
Cohort 40 507.06 12.68 464.04 13 <0.001 10790
Age-period 40 87.76 2.19 44.8 13 <0.001 10370
Age-cohort 30 69.51 2.31 26.55 3 <0.001 10372
Period-cohort 36 140.28 3.9 97.32 9 <0.001 10431
Age-period-cohort 27 42.96 1.59 Reference Reference Reference 10352
Female
Age 44 98.48 2.24 69.53 17 <0.001 11483
Period 50 407.97 8.16 379.02 23 <0.001 11780
Cohort 40 113.21 2.83 84.26 13 <0.001 11505
Age-period 40 75.99 1.9 47.04 13 <0.001 11468
Age-cohort 30 47.2 1.57 18.25 3 <0.001 11459
Period-cohort 36 42.19 1.17 13.24 9 0.152 11443
Age-period-cohort 27 28.95 1.07 Reference Reference Reference 11447
DF Degree of freedom, ΔDeviance increase in deviance from the APC model, ΔDF increase in DF from the APC model, AIC Akaike’s information criterion
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cholangiocarcinoma [9]. However, we were unable to dif-
ferentiate between types of PLC because the proportion
of histologically diagnosed PLC was small (9.14 %) and
only 2.5 % of the histologically diagnosed PLC cases can
be classified as a specific pathological subtype. Given the
symptoms of PLC are insidious at onset, progress quickly
and with high mortality, the disease is usually diagnosed
when the tumor is large and incurable. Therefore, patients
often refuse the pathological biopsy diagnosis and treat-
ment. Increasing the early detection rate and treatment ef-
fect might improve the pathologic diagnostic rate of PLC in
the future. Another limitation is we cannot analyze the ef-
fect of risk factors clearly for PLC cases due to the lack of
environmental risk factors exposure information.
The APC analysis suggests that population aging is one
of the effectors of the increasing PLC incidence in both
sexes. Indeed, PLC incidence increased progressively with
age, peaking in the 80–84 year age group. With economic
development and introduction of modern medical tech-
nology, the proportion of elderly in the general population
has increased dramatically. In 2010, the average life ex-
pectancy in Sihui (76.6 years) was longer than the national
by 3.1 years [34]. Age increases PLC risk due to the long
incubation process (about 50 years) from HBV infection
to PLC [35, 36], possibly conferring higher PLC risk for
the given infection rate.
Variations in incidence over long periods often re-
flect the impacts of new diagnostic techniques, im-
proved medical interventions, and greater accuracy in
determining the causes of morbidity and mortality.
According to the APC model, PLC incidence rates
were highest for both sexes in the first diagnostic
period included (1987–1991). In females, this period
was followed by a general decreasing trend, while in
males the rate trended downward only until 1997–
2001 and has since remained stable. The peak detec-
tion of PLC in the 1987–1991 period may be due to
the widespread introduction of ultrasound and AFP
measurement [10]. In the 1980s, ultrasound examin-
ation together with AFP testing has been gradually
popularized as a PLC screening method in the en-
demic areas in China, which led to a large number of
asymptomatic cases of PLC found and more frequent
neoplasms identified from cirrhotic patients [37, 38].
A birth cohort effect usually reflects early life ex-
posure to specific risk factors that were absent in
other periods [39]. In our study, birth cohort-
stratified incidences in males and females showed
two trends. Before the 1947–1951 cohort, a slow
progressive increase in PLC incidence was observed
in both males and females. However, there was a
sharp acceleration from the 1952–1956 to the 1968–
1972 cohort in younger males, whereas the equiva-
lent female cohorts showed only a narrow fluctu-
ation. We suggest that the combination of high HBV
and C. sinensis infection rates, exposure to cigarette
smoking and alcohol drinking in the younger male
generation may be the main reasons underlying this
birth cohort effect in males of Sihui. It has been re-
ported that males had higher prevalence rate than
females for HBs-Ag (23.56 vs 15.55 %, p < 0.05) [29]
and for C sinesis (18.92 vs 13.89 %, p < 0.05) [33].
Several studies conducted in 1980s-1990s reported
that the prevalence rates of cigarette smoking were
15 times higher (39.04 vs.2.47 %) and alcohol drink-
ing 21 times higher (38.24 vs 1.77 %) in the male
younger cohorts than females [40, 41]. These differ-
ences might result in a more rapid increase in PLC
Table 3 Relative risk (RR) and 95 % confidence interval (CI) of PLC
incidence for both sexes by age-period-cohort model in Sihui, China
Parameter Subgroup Males Females
RR 95 % CI RR 95 % CI
Age (years) 30–34 0.04 0.03–0.07 0.12 0.05–0.28
35–39 0.09 0.07–0.13 0.22 0.11–0.44
40–44 0.23 0.18–0.30 0.42 0.24–0.72
45–49 0.39 0.31–0.48 0.45 0.28–0.73
50–54 0.63 0.53–0.75 0.87 0.59–1.28
55–59 Reference Reference
60–64 1.24 1.03–1.49 1.54 1.06–2.21
65–69 1.96 1.57–2.45 2.27 1.48–3.49
70–74 2.36 1.78–3.12 2.49 1.48–4.18
75–79 3.23 2.26–4.61 2.80 1.49–5.26
80–84 3.61 2.20–5.96 3.86 1.78–8.36
Period 1987–1991 1.70 1.33–2.18 1.05 0.66–1.67
1992–1996 1.50 1.25–1.80 1.35 0.97–1.89
1997–2001 Reference Reference
2002–2006 0.96 0.86–1.07 0.70 0.55–0.88
2007–2011 1.00 0.91–1.25 1.00 0.61–1.52
Cohort 1910–1914 0.11 0.04–0.29 0.17 0.04–0.68
1915–1919 0.15 0.08–0.34 0.08 0.02–0.34
1920–1924 0.20 0.12–0.32 0.44 0.20–0.96
1925–1929 0.46 0.32–0.65 0.49 0.26–0.93
1930–1934 0.52 0.39–0.69 1.02 0.62–1.67
1935–1939 0.80 0.64–1.00 1.00 0.65–1.52
1940–1944 0.88 0.73–1.06 1.09 0.75–1.58
1945–1949 Reference Reference
1950–1954 1.51 1.24–1.82 1.67 1.12–2.50
1955–1959 2.03 1.63–2.54 1.68 1.04–2.70
1960–1964 2.22 1.70–2.90 1.24 0.69–2.23
1965–1969 2.60 1.88–3.61 1.59 0.78–3.21
1970–1974 4.18 2.84–6.15 1.13 0.47–2.71
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Fig. 3 Effect of age, period, and birth cohort on the relative risk of primary liver cancer incidence with APC regression analysis in Sihui county by sex.
a Age effects; b, Period effects; c, Birth cohort effects. The age effects for both sexes showed that the risk of PLC increased with age. Compared with
the age group of 55–59 years, the RR of PLC was up to 3.61(95 % CI:2.20–5.96) for males and 3,86 (95 % CI:1.78–8.36) for females in the oldest age
group (80–84 years) (Fig. 3a). Period effects for males depicted that the RRs decreased from 1987–1991 to 1997–2001, and then plateaued afterwards;
for females, RR fluctuated through the entire period. The RRs increased from period1987-1991 to 1992–1996, decreased consistently from 1992–1996
to 2002–2006, and then increased to the staring risk (Fig. 3b). By using the 1940–1944 birth cohort as the reference group, an obvious increased incidence
trend in both males and females were obtained; however, females had a plateau in the youngest cohorts who were born during 1955–1974 and males
had a sharp increasing trend in the cohorts who were born during 1965–1974 (Fig. 3c)
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incidence in men than women. More detailed infor-
mation on the risk factors for PLC should be gath-
ered from southern China.
Conclusions
A significant increase in the incidence rate of primary
liver cancer was observed in Sihui from 1987 to 2011 for
both sexes. Estimates from cohort effect showed that the
increasing trend in male is likely to continue over the
next decade in male, while female tended to leveled off
since 1950. Although the reasons for increasing PLC in-
cidence in Sihui are not fully clear, higher prevalences of
HBV and C. sinensis infection are likely contributors.
Further research exploring the prevalence of possible
risk factors associated with PLC is needed to formulate a
comprehensive PLC prevention and control strategy in
this region of southern China.
Appendix
Abbreviations
AFP: α-fetoprotein; AIC: Akaike’s information criterion; anti-HBs: Antibodies to HBV
surface antigen; APC: Age-Period-Cohort model; ASRs: Age-standardized rates; C.
sinensis: Clonorchis sinensis; CC: Cholangiocarcinoma; cHCC-CC: Combined
Hepatocellular and cholangiocarcinoma; DCN: Death Certification Notifications;
DF: Degree of freedom; EAPC: Estimated annual percent change; EAPCs: Estimate
annual percent changes; HBs-Ag: HBV surface antigens; HBV: Hepatitis B virus;
Table 4 Incidence rates of PLC in different age groups, period groups and birth cohort groups for both sexes in Sihui, China
Variable Subgroup Males Female
Cases Incidence rate (/100,000) Cases Incidence rate (/100,000)
Age (Years) 30–34 95 21.87 15 3.67
35–39 166 41.62 29 7.80
40–44 252 85.88 45 16.60
45–49 279 106.90 42 17.63
50–54 303 140.92 62 31.02
55–59 311 180.80 60 34.45
60–64 279 169.30 81 49.21
65–69 267 208.64 90 57.91
70–74 181 194.75 71 53.83
75–79 116 191.44 45 44.89
80–84 44 139.91 31 40.90
Period 1987–1991 323 34.02 78 8.43
1992–1996 422 41.82 129 13.49
1997–2001 379 37.71 379 40.00
2002–2006 506 48.65 96 9.85
2007–2011 659 62.20 152 15.09
Cohort 1910–1914 19 103.88 3 8.89
1915–1919 36 105.69 22 39.58
1920–1924 116 195.60 32 37.57
1925–1929 155 172.57 85 67.98
1930–1934 253 207.60 79 51.63
1935–1939 268 167.97 77 58.00
1940–1944 236 138.97 54 32.52
1945–1949 274 137.20 65 36.82
1950–1954 207 79.51 57 24.06
1955–1959 232 74.73 37 12.62
1960–1964 167 60.89 31 11.87
1965–1969 141 58.27 15 6.56
1970–1974 74 37.26 7 3.79
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HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; ICD-10: International
Classification of Diseases-10th revision; M:I: The Ratio of Mortality to Incidence;
PLC: Primary Liver Cancer; RR: Relative Risk; Δ Deviance: Increase in deviance from
the APC model; Δ DF: Increase in DF from the APC model
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